Tumor necrosis factor inhibitors in tumor necrosis factor receptor-associated periodic syndrome: still a chance to work?

被引:3
作者
Rigante, Donato [1 ]
机构
[1] Univ Cattolica Sacro Cuore, Inst Pediat, Fdn Policlin Univ Agostino Gemelli, Rome, Italy
关键词
Etanercept; Adalimumab; Familial Mediterranean Fever; Tocilizumab; Tumor Necrosis Factor Receptor;
D O I
10.1007/s11739-016-1570-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:269 / 270
页数:2
相关论文
共 50 条
  • [31] Tumor necrosis receptor associated periodic syndrome (TRAPS): State of the art
    Georgin-Lavialle, S.
    Kone-Paut, I.
    Delaleu, J.
    Sarrabay, G.
    Grateau, G.
    Touitou, I.
    Hentgen, V.
    REVUE DE MEDECINE INTERNE, 2018, 39 (04): : 256 - 264
  • [32] Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study
    Cantarini, Luca
    Lucherini, Orso Maria
    Brucato, Antonio
    Barone, Luca
    Cumetti, Davide
    Iacoponi, Francesca
    Rigante, Donato
    Brambilla, Giovanni
    Penco, Silvana
    Brizi, Maria Giuseppina
    Patrosso, Maria Cristina
    Valesini, Guido
    Frediani, Bruno
    Galeazzi, Mauro
    Cimaz, Rolando
    Paolazzi, Giuseppe
    Vitale, Antonio
    Imazio, Massimo
    CLINICAL RESEARCH IN CARDIOLOGY, 2012, 101 (07) : 525 - 531
  • [33] Tumor Necrosis Factor-α Blockers in SAPHO Syndrome
    Ben Abdelghani, Kaouther
    Dran, Delphine Gerard
    Gottenberg, Jacques-Eric
    Morel, Jacques
    Sibila, Jean
    Combe, Bernard
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (08) : 1699 - 1704
  • [34] Infections associated with tumor necrosis factor-α antagonists
    Rychly, DJ
    DiPiro, JT
    PHARMACOTHERAPY, 2005, 25 (09): : 1181 - 1192
  • [35] Evidence based recommendations for diagnosis and treatment of tumor necrosis factor receptor-1 associated periodic syndrome (TRAPS)
    Nienke Ter Haar
    Paul Brogan
    Gilles Grateau
    Jordi Anton-Lopez
    Karyl Barron
    Luca Cantarini
    Joost Frenkel
    Caroline Galeotti
    Veronique Hentgen
    Michael Hofer
    Tilmann Kallinich
    Isabelle Kone-Paut
    Jasmin Kümmerle-Deschner
    Huri Ozdogan
    Seza Ozen
    Anna Simon
    Yosef Uziel
    Carine Wouters
    Brian Feldman
    Bas Vastert
    Nico Wulffraat
    Helen Lachmann
    Marco Gattorno
    Pediatric Rheumatology, 12 (Suppl 1)
  • [36] Mechanisms of differential immunogenicity of tumor necrosis factor inhibitors.
    Anderson P.
    Louie J.
    Lau A.
    Broder M.
    Current Rheumatology Reports, 2005, 7 (1) : 3 - 9
  • [37] Neurosarcoidosis in a patient treated with tumor necrosis factor alpha inhibitors
    Yang Mao-Draayer
    Tiyonnoh Cash
    Journal of Neurology, 2013, 260 : 651 - 653
  • [38] Serum leptin, resistin, visfatin and adiponectin levels in tumour necrosis factor receptor-associated periodic syndrome (TRAPS)
    Cantarini, L.
    Obici, L.
    Simonini, G.
    Cimaz, R.
    Bacarelli, M. R.
    Merlini, G.
    Vitale, A.
    Lucherini, O. M.
    Brizi, M. G.
    Galeazzi, M.
    Fioravanti, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (03) : S108 - S114
  • [39] Tumor necrosis factor α inhibitors and methotrexate:: Implications for deployed personnel
    Martin, JJ
    AVIATION SPACE AND ENVIRONMENTAL MEDICINE, 2005, 76 (12): : 1162 - 1166
  • [40] Efficacy of Tumor Necrosis Factor Inhibitors in Patients With Ankylosing Spondylitis
    Dulgeroglu Erdogdu, Deniz
    Bal, Ajda
    Karaahmet, Ozgur
    Erkoc, Sibel
    Yalcin, Tugba
    Cakci, Aytul
    ARCHIVES OF RHEUMATOLOGY, 2014, 29 (04) : 257 - 266